Smartleaf Asset Management
USNA icon

Smartleaf Asset Management’s Usana Health Sciences USNA Stock Holding History

Smartleaf Asset Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$514 Buy
+35
New +$602 ﹤0.01% 3332
2025
Q1 		– Sell
-12
Closed -$423 – 3009
2024
Q4 		$423 Buy
+12
New +$449 ﹤0.01% 2805

Other funds holding USNA

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Smartleaf Asset Management's USNA Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Usana Health Sciences (USNA) in Q3 2026: 35 shares worth $514. The stake represents ﹤0.01% of the portfolio and ranks #3332 among its holdings. This is a return to the name: Smartleaf Asset Management previously reported a position in USNA as recently as Q4 2024.

Smartleaf Asset Management first reported a position in USNA in Q4 2024 and has held it in 2 quarters since. 57 funds tracked by Wall St. Rank hold USNA as of Q3 2026.

  • Smartleaf Asset Management held 35 shares of Usana Health Sciences worth $514 as of Q3 2026.
  • Usana Health Sciences was a new Smartleaf Asset Management position in Q3 2026.
  • Usana Health Sciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3332 holding.
  • Smartleaf Asset Management first reported a position in Usana Health Sciences in Q4 2024 and has held it in 2 quarters since.
  • 57 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.